79 related articles for article (PubMed ID: 6982956)
21. Studies on proteases and alpha-macroglobulin activity in amphibian blood plasma.
Kumar RS
Indian J Exp Biol; 1997 Nov; 35(11):1198-202. PubMed ID: 9567750
[TBL] [Abstract][Full Text] [Related]
22. Standardized automated assay for functional alpha 1-antitrypsin.
Mullins RE; Miller RL; Hunter RL; Bennett B
Clin Chem; 1984 Nov; 30(11):1857-60. PubMed ID: 6333300
[TBL] [Abstract][Full Text] [Related]
23. The intrinsic coagulation activity assay.
Stief TW; Otto S; Renz H
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
[TBL] [Abstract][Full Text] [Related]
24. Creatine-kinase MB mass: age and sex-associated reference limits in two different platforms that use the same method.
Zaninotto M; Mion MM; Novello E; Delprete E; Moretti M; Plebani M
Clin Chim Acta; 2009 Mar; 401(1-2):162-4. PubMed ID: 19101529
[TBL] [Abstract][Full Text] [Related]
25. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen levels in hypercholesterolemic smokers and non-smokers in relation to age and gender.
Schuitemaker GE; Dinant GJ; van der Pol GA; van Wersch JW
Clin Exp Med; 2004 Apr; 3(4):231-5. PubMed ID: 15103514
[TBL] [Abstract][Full Text] [Related]
27. Effects of age, sex, reproductive status, and hospitalization on serum alpha 1-antitrypsin concentration in dogs.
Hughes D; Elliott DA; Washabau RJ; Kueppers F
Am J Vet Res; 1995 May; 56(5):568-72. PubMed ID: 7661449
[TBL] [Abstract][Full Text] [Related]
28. Automated assay for alpha 1-antitrypsin with N-alpha-benzoyl-DL-arginine-p-nitroanilide as trypsin substrate and standardized with p-nitrophenyl-p'-guanidinobenzoate as titrant for trypsin active sites.
Eckfeldt JH; Light RT; Leiendecker-Foster C
Clin Chem; 1982 May; 28(5):1108-12. PubMed ID: 6280895
[TBL] [Abstract][Full Text] [Related]
29. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.
Sousa MO; Miranda TL; Maia CN; Bittar ER; Santoro MM; Figueiredo AF
Arch Biochem Biophys; 2002 Apr; 400(1):7-14. PubMed ID: 11913965
[TBL] [Abstract][Full Text] [Related]
30. Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants.
Coakley J; Kellie SJ; Nath C; Munas A; Cooke-Yarborough C
Ann Clin Biochem; 2005 Jan; 42(Pt 1):24-9. PubMed ID: 15802029
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
Lanevschi A; Kramer JW; Greene SA; Meyers KM
Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
[TBL] [Abstract][Full Text] [Related]
32. A novel chromogenic peptide for prekallikrein/kallikrein determination.
Huang WY; Wan X; Zhang S
Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
[TBL] [Abstract][Full Text] [Related]
33. [The dynamics of the alpha 1-protease inhibitor and alpha 2-macroglobulin in very-low-birth-weight newborns].
Porozhanova V; Bozhinova S; Nankova D; Velkova A
Akush Ginekol (Sofiia); 1998; 37(3):21-3. PubMed ID: 10204260
[TBL] [Abstract][Full Text] [Related]
34. [The measurement of antioxidant activity in human plasma using cumene hydroperoxide].
Sugita O; Nakano M; Matsuto T; Miida T; Okada M
Rinsho Byori; 1998 Mar; 46(3):271-6. PubMed ID: 9564767
[TBL] [Abstract][Full Text] [Related]
35. [Biological variations and reference values of transferrin, immunoglobulin A and orosomucoid].
Herbeth B; Henny J; Siest G
Ann Biol Clin (Paris); 1983; 41(1):23-32. PubMed ID: 6408953
[TBL] [Abstract][Full Text] [Related]
36. Intravenous human plasma-derived augmentation therapy in alpha 1-antitrypsin deficiency: from pharmacokinetic analysis to individualizing therapy.
Zamora NP; Pla RV; Del Rio PG; Margaleff RJ; Frias FR; Ronsano JB
Ann Pharmacother; 2008 May; 42(5):640-6. PubMed ID: 18413692
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
[TBL] [Abstract][Full Text] [Related]
38. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
39. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
Topper MJ; Prasse KW
Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
[TBL] [Abstract][Full Text] [Related]
40. Specific determination of plasmatic thrombin activity.
Stief TW
Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
